Protein Modification by O-Linked GlcNAc Reduces Angiogenesis by Inhibiting Akt Activity in Endothelial Cells
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (4) , 651-657
- https://doi.org/10.1161/atvbaha.107.159533
Abstract
Objective—Glucose flux through the hexosamine biosynthesis pathway (HBP) has been implicated in the development of diabetic vascular complications. O-linked N-acetylglucosamine (O-GlcNAc) modification on protein is the major mechanism mediating the actions of the HBP. Impaired angiogenesis is well-recognized in diabetes; however, the mechanisms are not completely defined. Here, we investigated the role of protein O-GlcNAc modification in angiogenesis.Methods and Results—In a mouse aortic ring assay, elevated O-GlcNAc levels induced by high-fat diet, streptozotocin-induced diabetes, or in vitro glucosamine treatment were associated with impaired angiogenesis. In cultured human umbilical vein endothelial cells and EA.hy926 endothelial cells, glucosamine increased protein O-GlcNAc modification and inhibited cell migration and capillary-like structure formation. Conversely, removal of O-GlcNAc by adenoviral-mediated overexpression of O-GlcNAcase improved these steps of angiogenesis. Also, high concentrations of glucose reduced capillary-like structure formation of human umbilical vein endothelial cells. Akt was recognized by an O-GlcNAc specific lectin, and glucosamine increased the amounts of Akt protein in these lectin precipitates. Increased glycosylation paralleled reduced Akt activity in endothelial cells.Conclusion—These results suggest that elevated protein O-GlcNAc modification through the HBP impairs angiogenesis in endothelial cells, possibly by inhibiting Akt signaling.Keywords
This publication has 43 references indexed in Scilit:
- Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in DiabetesDiabetes, 2006
- Akt1 is dynamically modified with O‐GlcNAc following treatments with PUGNAc and insulin‐like growth factor‐1FEBS Letters, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytesExperimental & Molecular Medicine, 2005
- Current methods for assaying angiogenesisin vitroandin vivoInternational Journal of Experimental Pathology, 2004
- O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stressPublished by Elsevier ,2004
- O-GlcNAc modification: a nutritional sensor that modulates proteasome functionTrends in Cell Biology, 2004
- AMP-activated Protein Kinase (AMPK) Signaling in Endothelial Cells Is Essential for Angiogenesis in Response to Hypoxic StressJournal of Biological Chemistry, 2003
- Insulin Resistance of Glycogen Synthase Mediated byO-Linked N-AcetylglucosamineJournal of Biological Chemistry, 2003
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001